429 related articles for article (PubMed ID: 11573897)
1. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence.
Hargreaves NJ; Kadzakumanja O; Whitty CJ; Salaniponi FM; Harries AD; Squire SB
Int J Tuberc Lung Dis; 2001 Sep; 5(9):847-54. PubMed ID: 11573897
[TBL] [Abstract][Full Text] [Related]
2. What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence?
Hargreaves NJ; Kadzakumanja O; Phiri S; Nyangulu DS; Salaniponi FM; Harries AD; Squire SB
Int J Tuberc Lung Dis; 2001 Feb; 5(2):113-22. PubMed ID: 11258504
[TBL] [Abstract][Full Text] [Related]
3. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.
Banda H; Kang'ombe C; Harries AD; Nyangulu DS; Whitty CJ; Wirima JJ; Salaniponi FM; Maher D; Nunn P
Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of an unsupervised ambulatory treatment regimen for smear-negative pulmonary tuberculosis and tuberculous pleural effusion in Malawi.
Harries AD; Nyangulu DS; Banda H; Kang'ombe C; Van der Paal L; Glynn JR; Subramanyam VR; Wirima JJ; Salaniponi FM; Maher D; Nunn P
Int J Tuberc Lung Dis; 1999 May; 3(5):402-8. PubMed ID: 10331729
[TBL] [Abstract][Full Text] [Related]
5. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi.
Glynn JR; Warndorff DK; Fine PE; Munthali MM; Sichone W; Pönnighaus JM
Bull World Health Organ; 1998; 76(3):295-305. PubMed ID: 9744250
[TBL] [Abstract][Full Text] [Related]
6. Three-year follow-up of patients with pulmonary tuberculosis in Guinea-Bissau, West Africa.
Winqvist N; Nauclér A; Gomes V; Djamanca I; Koivula T; Jensen H; Dias F; Biberfeld G; Källenius G; Norberg R
Int J Tuberc Lung Dis; 2000 Sep; 4(9):845-52. PubMed ID: 10985653
[TBL] [Abstract][Full Text] [Related]
7. National profile and treatment outcomes of adult smear-negative pulmonary TB patients in Benin.
Ade S; Harries AD; Trébucq A; Hinderaker SG; Adè G; Agodokpessi G; Affolabi D; Anagonou S
Trans R Soc Trop Med Hyg; 2013 Dec; 107(12):783-8. PubMed ID: 24218414
[TBL] [Abstract][Full Text] [Related]
8. Management of pulmonary tuberculosis suspects with negative sputum smears and normal or minimally abnormal chest radiographs in resource-poor settings.
Harries AD; Banda HT; Boeree MJ; Welby S; Wirima JJ; Subramanyam VR; Maher D; Nunn P
Int J Tuberc Lung Dis; 1998 Dec; 2(12):999-1004. PubMed ID: 9869116
[TBL] [Abstract][Full Text] [Related]
9. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection.
El-Sony AI; Khamis AH; Enarson DA; Baraka O; Mustafa SA; Bjune G
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1058-66. PubMed ID: 12546113
[TBL] [Abstract][Full Text] [Related]
10. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
Kliiman K; Altraja A
Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
[TBL] [Abstract][Full Text] [Related]
11. Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes.
Harries AD; Hargreaves NJ; Graham SM; Mwansambo C; Kazembe P; Broadhead RL; Maher D; Salaniponi FM
Int J Tuberc Lung Dis; 2002 May; 6(5):424-31. PubMed ID: 12019918
[TBL] [Abstract][Full Text] [Related]
12. Voluntary counselling, HIV testing and adjunctive cotrimoxazole are associated with improved TB treatment outcomes under routine conditions in Thyolo District, Malawi.
Chimzizi R; Gausi F; Bwanali A; Mbalume D; Teck R; Gomani P; Zachariah R; Zuza W; Malombe R; Salaniponi FM; Harries AD
Int J Tuberc Lung Dis; 2004 May; 8(5):579-85. PubMed ID: 15137534
[TBL] [Abstract][Full Text] [Related]
13. Decentralisation of tuberculosis services in an urban setting, Lilongwe, Malawi.
Nyirenda TE; Harries AD; Gausi F; van Gorkom J; Maher D; Floyd K; Salaniponi FM
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S21-8. PubMed ID: 12971651
[TBL] [Abstract][Full Text] [Related]
14. Decentralisation of treatment for patients with tuberculosis in Malawi: moving from research to policy and practice.
Salaniponi FM; Gausi F; Mphasa N; Nyirenda TE; Kwanjana JH; Harries AD
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S38-47. PubMed ID: 12971653
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
16. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
[TBL] [Abstract][Full Text] [Related]
17. Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region.
van den Boogaard J; Lyimo R; Irongo CF; Boeree MJ; Schaalma H; Aarnoutse RE; Kibiki GS
Int J Tuberc Lung Dis; 2009 Dec; 13(12):1524-9. PubMed ID: 19919771
[TBL] [Abstract][Full Text] [Related]
18. Auditing the new decentralised oral treatment regimens in Malawi.
Nyirenda TE; Harries AD; Gausi FK; Ito K; Kemp JR; Squire BS; Godfrey-Faussett P; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Sep; 8(9):1089-94. PubMed ID: 15455593
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand.
Punnotok J; Shaffer N; Naiwatanakul T; Pumprueg U; Subhannachart P; Ittiravivongs A; Chuchotthaworn C; Ponglertnapagorn P; Chantharojwong N; Young NL; Limpakarnjanarat K; Mastro TD
Int J Tuberc Lung Dis; 2000 Jun; 4(6):537-43. PubMed ID: 10864184
[TBL] [Abstract][Full Text] [Related]
20. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
